(Q38191832)

30 August 2017

1 reference

title

Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy (English)

1 reference

30 August 2017

1 reference

5

Ick Chan Kwon

1 reference

30 August 2017

2

Kwangmeyung Kim

1 reference

30 August 2017

3

Kuiwon Choi

1 reference

30 August 2017

Sook Hee Ku

1

1 reference

30 August 2017

Sun Hwa Kim

series ordinal

4

1 reference

30 August 2017

publication date

28 February 2014

1 reference

Advanced Healthcare Materials

30 August 2017

published in

1 reference

30 August 2017

volume

3

1 reference

30 August 2017

issue

8

1 reference

30 August 2017

page(s)

1182-1193

1 reference

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Molecular basis for target RNA recognition and cleavage by human RISC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

A review of the current status of siRNA nanomedicines in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

RNA interference and chemically modified small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Chemical modification: the key to clinical application of RNA interference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

siRNA delivery systems for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Drug targeting and tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

High interstitial fluid pressure - an obstacle in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Folate-targeted therapeutic and imaging agents for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Nanoparticle-aptamer bioconjugates for cancer targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Biophysical and biological properties of quadruplex oligodeoxyribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Cyclodextrin-based pharmaceutics: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Targeted gene silencing using RGD-labeled chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Tumor-targeted delivery of siRNA by self-assembled nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Dendronized gold nanoparticles for siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Layer-by-layer assembled gold nanoparticles for siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Effective gene silencing by multilayered siRNA-coated gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

In vivo imaging of siRNA delivery and silencing in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Clustered magnetite nanocrystals cross-linked with PEI for efficient siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

SiRNA delivery with functionalized carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Transport properties of two finite armchair graphene nanoribbons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Photothermally controlled gene delivery by reduced graphene oxide-polyethylenimine nanocomposite

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Dual gene targeted multimeric siRNA for combinatorial gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300607

21 January 2018

Identifiers

DOI

10.1002/ADHM.201300607

1 reference

30 August 2017

1 reference